FDA allowing this technology to move forward to clinical investigation marks key milestone for regenerative hydrogel platform in treating complex colorectal conditions. WARRENDALE, Pa., May 06, 2025-- ...
Trial records are sourced from ClinicalTrials.gov and indexed using natural language processing techniques, including named entity recognition, term normalization, and relationship extraction.
ECM Therapeutics, Inc. (“ECMT”) has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application for ECMT-100, a hydrogel derived from complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results